Weibo Xu
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- Biochemistry top 5%
Papers in
-
- RNA modifications and cancer 10
-
- Cancer-related molecular mechanisms research 9
- MicroRNA in disease regulation 5
- Co-authors
- Junkai Chang (8 shared papers)Xinyi Du (5 shared papers)Junqing Hou (7 shared papers)Delinda A. Johnson (1 shared paper)Glen K. Andrews (1 shared paper)Jeffrey Johnson (1 shared paper)Jianli Hua (8 shared papers)Zhicheng Yang (6 shared papers)
- Journals
- OncoTargets and Therapy (3 papers)Frontiers in Plant Science (2 papers)Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2 papers)Biomedicine & Pharmacotherapy (2 papers)Frontiers in Oncology (2 papers)
- Partner nations
- ChinaUnited StatesRussia
In The Last Decade
Weibo Xu
51 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 112
- Cancer Research 322
- Biochemistry 84
- Endocrinology, Diabetes and Metabolism 151
- Molecular Biology 576
- Biological Psychiatry 20
Countries citing papers authored by Weibo Xu
This map shows the geographic impact of Weibo Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weibo Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weibo Xu more than expected).
Fields of papers citing papers by Weibo Xu
This network shows the impact of papers produced by Weibo Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weibo Xu. The network helps show where Weibo Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Weibo Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 140 | |
| 2 | 2017 | 76 | |
| 3 | 2019 | 66 | |
| 4 | 2018 | 63 | |
| 5 | 2018 | 61 | |
| 6 | 2021 | 54 | |
| 7 | 2022 | 42 | |
| 8 | 2022 | 39 | |
| 9 | 2021 | 38 | |
| 10 | 2019 | 38 | |
| 11 | 2019 | 34 | |
| 12 | 2016 | 34 | |
| 13 | 2020 | 33 | |
| 14 | 2019 | 32 | |
| 15 | 2020 | 28 | |
| 16 | 2022 | 24 | |
| 17 | 2020 | 24 | |
| 18 | 2017 | 21 | |
| 19 | 2019 | 20 | |
| 20 | 2022 | 19 |
About Weibo Xu
Weibo Xu is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Spectroscopy, having authored 52 papers that have together received 1.2k indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (11 papers), RNA modifications and cancer (10 papers), Ferroptosis and cancer prognosis (9 papers), Cancer-related molecular mechanisms research (9 papers), Molecular Sensors and Ion Detection (7 papers), Nanoplatforms for cancer theranostics (5 papers), MicroRNA in disease regulation (5 papers) and Luminescence and Fluorescent Materials (5 papers). The work is most often cited by research in Cancer Research (322 citations), Biochemistry (84 citations), Endocrinology, Diabetes and Metabolism (151 citations), Molecular Biology (576 citations) and Biological Psychiatry (20 citations). Weibo Xu has collaborated with scholars based in China, United States and Russia. Frequent co-authors include Junkai Chang, Xinyi Du, Junqing Hou, Delinda A. Johnson, Glen K. Andrews, Jeffrey Johnson, Jianli Hua, Zhicheng Yang, Ben Ma and Tian Liao. Their work appears in journals such as OncoTargets and Therapy, Frontiers in Plant Science, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, Biomedicine & Pharmacotherapy and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.